Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| North Haven Net REITNONE · Entity 53573 | Director | April 03, 2026 | April 06, 2026 |
| OMEGA HEALTHCARE INVESTORS INCOHI · Entity 3362 | Director | June 05, 2026 | June 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
North Haven Net REIT
Report date April 03, 2026 · Filed April 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class E Common SharesSEC Table I · non-derivative | Direct | 4,431.764 |
Reported balance
After 2026-04-03 transaction · row 1
1 source rowRow 1 · 2026-04-03 · Grant · Acquired 1,394 · Balance 4,431.764 F1: Represents a grant of restricted common shares, which will vest on April 3, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted common shares, which will vest on April 3, 2027.
OMEGA HEALTHCARE INVESTORS INC
Report date June 05, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Profits Interest UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-05 · Exercise / conversion · Disposed 11,263 · Balance 0 F1: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. The OP Units have no expiration date. |
| Profits Interest UnitsSEC Table II · derivative / convertible security | Direct | 9,708 |
Reported balance
After 2026-06-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-05 · Grant · Acquired 9,708 · Balance 9,708 F1: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. The OP Units have no expiration date. F4: Represents the annual grant of stock the reporting person elected to receive as Profits Interest Units. F5: 100% of the reporting person's PIUs granted on June 5, 2026 will vest on the date of the Company's 2027 Annual Meeting of Shareholders, subject to continued service. |
| OP UnitsSEC Table II · derivative / convertible security | Direct | 74,310 |
Reported balance
After 2025-06-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-06 · Exercise / conversion · Acquired 11,263 · Balance 74,310 F2: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. The OP Units have no expiration date. F3: 100% of the reporting person's PIUs granted on June 6, 2025 vested and converted into OP Units on June 5, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements.
F2: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. The OP Units have no expiration date.
F3: 100% of the reporting person's PIUs granted on June 6, 2025 vested and converted into OP Units on June 5, 2026.
F4: Represents the annual grant of stock the reporting person elected to receive as Profits Interest Units.
F5: 100% of the reporting person's PIUs granted on June 5, 2026 will vest on the date of the Company's 2027 Annual Meeting of Shareholders, subject to continued service.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HMS HOLDINGS CORP
Report date March 31, 2021 · Filed April 01, 2021
Section 16 reporting ended · disclosed 2021-04-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-04-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-03-31 · Grant · Acquired 777 · Balance 67,410 F1: Represents deferred stock units acquired under the Issuer's Director Deffered Compensation Plan in lieu of all or a portion of the Reporting Person's quarterly cash retaining fees for Board services, which are payable in shares of the Issuer's common stock. Row 2 · 2021-04-01 · Disposition to issuer · Disposed 67,410 · Balance 0 F2: On April 1, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of December 20, 2020 (the "Merger Agreement"), by and among the Issuer, Gainwell Acquisition Corp. ("Gainwell"), Mustang Merger Sub, Inc. ("Merger Sub") and Gainwell Intermediate Holding Corp., Merger Sub merged with and into the Issuer with the Issuer surviving as a wholly owned subsidiary of IRC (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each share of common stock of the Issuer was cancelled and converted into the right to receive $37.00 per share in cash (the "Per Share Merger Consideration"). In addition, each unvested restricted stock unit automatically vested and was converted in the right to receive the Per Share Merger Consideration. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.20 · Expires 2022-11-10 | Direct | 0 |
Reported balance
After 2021-04-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-04-01 · Disposition to issuer · Disposed 8,349 · Balance 0 F3: Pursuant to the procedures set forth in the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock with a per share exercise price that is less than the Per Share Merger Consideration that is outstanding and unexercised, was cancelled and converted into the right to receive a cash payment equal to the product of (x) the Per Share Merger Consideration, net of the applicable per share exercise price and (y) the aggregate number of shares of Common Stock subject to the option, less applicable withholding taxes or other amounts required by law. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.54 · Expires 2026-11-11 | Direct | 0 |
Reported balance
After 2021-04-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-04-01 · Disposition to issuer · Disposed 3,740 · Balance 0 F3: Pursuant to the procedures set forth in the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock with a per share exercise price that is less than the Per Share Merger Consideration that is outstanding and unexercised, was cancelled and converted into the right to receive a cash payment equal to the product of (x) the Per Share Merger Consideration, net of the applicable per share exercise price and (y) the aggregate number of shares of Common Stock subject to the option, less applicable withholding taxes or other amounts required by law. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.45 · Expires 2027-08-21 | Direct | 0 |
Reported balance
After 2021-04-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-04-01 · Disposition to issuer · Disposed 6,743 · Balance 0 F3: Pursuant to the procedures set forth in the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock with a per share exercise price that is less than the Per Share Merger Consideration that is outstanding and unexercised, was cancelled and converted into the right to receive a cash payment equal to the product of (x) the Per Share Merger Consideration, net of the applicable per share exercise price and (y) the aggregate number of shares of Common Stock subject to the option, less applicable withholding taxes or other amounts required by law. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.19 · Expires 2028-05-23 | Direct | 0 |
Reported balance
After 2021-04-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-04-01 · Disposition to issuer · Disposed 5,367 · Balance 0 F3: Pursuant to the procedures set forth in the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock with a per share exercise price that is less than the Per Share Merger Consideration that is outstanding and unexercised, was cancelled and converted into the right to receive a cash payment equal to the product of (x) the Per Share Merger Consideration, net of the applicable per share exercise price and (y) the aggregate number of shares of Common Stock subject to the option, less applicable withholding taxes or other amounts required by law. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.63 · Expires 2021-11-11 | Direct | 0 |
Reported balance
After 2021-04-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-04-01 · Disposition to issuer · Disposed 3,422 · Balance 0 F3: Pursuant to the procedures set forth in the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock with a per share exercise price that is less than the Per Share Merger Consideration that is outstanding and unexercised, was cancelled and converted into the right to receive a cash payment equal to the product of (x) the Per Share Merger Consideration, net of the applicable per share exercise price and (y) the aggregate number of shares of Common Stock subject to the option, less applicable withholding taxes or other amounts required by law. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.71 · Expires 2030-05-27 | Direct | 0 |
Reported balance
After 2021-04-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-04-01 · Disposition to issuer · Disposed 4,384 · Balance 0 F3: Pursuant to the procedures set forth in the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock with a per share exercise price that is less than the Per Share Merger Consideration that is outstanding and unexercised, was cancelled and converted into the right to receive a cash payment equal to the product of (x) the Per Share Merger Consideration, net of the applicable per share exercise price and (y) the aggregate number of shares of Common Stock subject to the option, less applicable withholding taxes or other amounts required by law. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.57 · Expires 2029-05-22 | Direct | 0 |
Reported balance
After 2021-04-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-04-01 · Disposition to issuer · Disposed 4,178 · Balance 0 F3: Pursuant to the procedures set forth in the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock with a per share exercise price that is less than the Per Share Merger Consideration that is outstanding and unexercised, was cancelled and converted into the right to receive a cash payment equal to the product of (x) the Per Share Merger Consideration, net of the applicable per share exercise price and (y) the aggregate number of shares of Common Stock subject to the option, less applicable withholding taxes or other amounts required by law. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents deferred stock units acquired under the Issuer's Director Deffered Compensation Plan in lieu of all or a portion of the Reporting Person's quarterly cash retaining fees for Board services, which are payable in shares of the Issuer's common stock.
F2: On April 1, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of December 20, 2020 (the "Merger Agreement"), by and among the Issuer, Gainwell Acquisition Corp. ("Gainwell"), Mustang Merger Sub, Inc. ("Merger Sub") and Gainwell Intermediate Holding Corp., Merger Sub merged with and into the Issuer with the Issuer surviving as a wholly owned subsidiary of IRC (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each share of common stock of the Issuer was cancelled and converted into the right to receive $37.00 per share in cash (the "Per Share Merger Consideration"). In addition, each unvested restricted stock unit automatically vested and was converted in the right to receive the Per Share Merger Consideration.
F3: Pursuant to the procedures set forth in the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock with a per share exercise price that is less than the Per Share Merger Consideration that is outstanding and unexercised, was cancelled and converted into the right to receive a cash payment equal to the product of (x) the Per Share Merger Consideration, net of the applicable per share exercise price and (y) the aggregate number of shares of Common Stock subject to the option, less applicable withholding taxes or other amounts required by law.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2017 Filed Nov 3, 2017 18:59 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | PurchaseCommon Stock | 10,000 | $27.38 | $273,800.00 |
DisclosureSEC source: 0001127602-17-031171 · form4.xml · nonDerivative · entry 1 CALLEN CRAIG R · CIK 0001224316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 22:05 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantNonqualified Stock Option (Right to Buy) · Derivative | 6,743 | $0.00 Strike: $17.45 | $0.00 |
DisclosureSEC source: 0001225208-17-014257 · doc4.xml · derivative · entry 2 CALLEN CRAIG R · CIK 0001224316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,743 Underlying: Common Stock · 6,743 shares Expires 2027-08-21 F2 · derivative.exercise_date: The option vests in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2018 annual meeting of stockholders. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 22:05 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantCommon Stock | 6,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014257 · doc4.xml · nonDerivative · entry 1 CALLEN CRAIG R · CIK 0001224316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,784 F1 · shares: Represents restricted stock units (RSUs) payable in an equal number of shares of the Issuer's common stock. The RSUs vest in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2018 annual meeting of stockholders. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 15:09 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantDeferred Stock Units · Derivative | 6,164 | $31.23 | $192,501.72 |
DisclosureSEC source: 0001127602-17-021030 · form4.xml · derivative · entry 1 CALLEN CRAIG R · CIK 0001224316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,667 Underlying: Common Stock · 6,164 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Plan: These units represent the grant of stock to the reporting person and convert into shares of common stock on a 1 for 1 basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2 · shares: Represents annual grant of restricted stock, elected to be taken as Deferred Stock Units, to the reporting person. The restricted units are subject to time based vesting. F3 · derivative.exercise_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. F3 · derivative.expiration_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. Read SEC document |
| June 02, 2017 Filed Jun 5, 2017 19:58 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | PurchaseCommon Stock | 15,000 | $31.40 | $471,037.50 |
DisclosureSEC source: 0001127602-17-020491 · form4.xml · nonDerivative · entry 1 CALLEN CRAIG R · CIK 0001224316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| May 16, 2017 Filed May 18, 2017 21:14 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantDeferred Stock Units · Derivative | 376 | $33.23 | $12,494.48 |
DisclosureSEC source: 0001127602-17-018699 · form4.xml · derivative · entry 1 CALLEN CRAIG R · CIK 0001224316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,503 Underlying: Common Stock · 376 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Plan: These units represent the grant of stock to the reporting person and convert into shares of common stock on a 1 for 1 basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2 · shares: Grant of stock, elected to be taken as deferred stock units, as payment of quarterly Director compensation. F3 · derivative.exercise_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. F3 · derivative.expiration_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 20:10 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantDeferred Stock Units · Derivative | 401 | $31.19 | $12,507.19 |
DisclosureSEC source: 0001127602-17-007328 · form4.xml · derivative · entry 1 CALLEN CRAIG R · CIK 0001224316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,734 Underlying: Common Stock · 401 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Plan: These units represent the grant of stock to the reporting person and convert into shares of common stock on a 1 for 1 basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2 · shares: Grant of stock, elected to be taken as deferred stock units, as payment of quarterly Director compensation. F3 · derivative.exercise_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. F3 · derivative.expiration_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. F4 · balance_after: Total includes 397 deferred shares granted to the reporting person by the Company equivalent to and in lieu of the quarterly cash dividend on their deferred shares. Read SEC document |
| November 16, 2016 Filed Nov 17, 2016 20:37 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantDeferred Stock Units · Derivative | 433 | $28.89 | $12,509.37 |
DisclosureSEC source: 0001127602-16-067556 · form4.xml · derivative · entry 1 CALLEN CRAIG R · CIK 0001224316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,533 Underlying: Common Stock · 433 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Plan: These units represent the grant of stock to the reporting person and convert into shares of common stock on a 1 for 1 basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2 · shares: Grant of stock, elected to be taken as deferred stock units, as payment of quarterly Director compensation. F3 · derivative.exercise_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. F3 · derivative.expiration_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 23:19 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantNonqualified Stock Option (Right to Buy) · Derivative | 3,740 | $0.00 Strike: $16.54 | $0.00 |
DisclosureSEC source: 0001225208-16-041721 · doc4.xml · derivative · entry 2 CALLEN CRAIG R · CIK 0001224316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,740 Underlying: Common Stock · 3,740 shares Expires 2026-11-11 F2 · derivative.exercise_date: The option vests 25% a quarter over four calendar quarters, with the first 25% vesting on December 31 of the year of grant and 25% vesting on the last day of each subsequent quarter. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 23:19 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantCommon Stock | 3,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-041721 · doc4.xml · nonDerivative · entry 1 CALLEN CRAIG R · CIK 0001224316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,041 F1 · shares: Represents restricted stock units (RSUs) payable in an equal number of shares of the Issuer's common stock. The RSUs vest 25% a quarter over four calendar quarters, with the first 25% vesting on December 31 of the year of grant and 25% vesting on the last day of each subsequent quarter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.